Zhengye Biotechnology Hol... (ZYBT)
7.14
1.37 (23.74%)
At close: Apr 16, 2025, 12:26 PM
Company Description
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.
It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs.
The company also exports its products to Vietnam, Pakistan, and Egypt.
The company was founded in 2004 and is based in Jilin, China.
Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Zhengye Biotechnology Holding Limited
| Country | CN |
| IPO Date | Jan 7, 2025 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 278 |
| CEO | Songlin Song |
Contact Details
Address: No.1 Lianmeng Road Jilin, CN | |
| Website | https://www.jlzybio.com |
Stock Details
| Ticker Symbol | ZYBT |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001975641 |
| CUSIP Number | n/a |
| ISIN Number | KYG989MS1016 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Aiden Han | Co-Chief Executive Officer |
| Songlin Song | Chief Executive Officer |
| Ping Wang | Chief Financial Officer |
| Zhongyao Liu | Chief Operating Officer |
| Wei Lian | Vice General Manager |
| Yuhong Cheng | Vice General Manager |
| Yuyou He | Vice General Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 03, 2025 | 6-K | Filing |
| Mar 06, 2025 | 6-K | Filing |
| Feb 21, 2025 | SCHEDULE 13G | Filing |
| Jan 14, 2025 | 6-K | Filing |
| Jan 08, 2025 | 6-K | Filing |
| Jan 07, 2025 | 424B4 | Filing |
| Jan 06, 2025 | CERT | Filing |
| Dec 19, 2024 | 8-A12B | Filing |
| Dec 09, 2024 | POS AM | Filing |
| Nov 21, 2024 | FWP | Filing |